LEF1 and hematologic disorder: Several human hematologic malignancies exhibit abnormal expression of lymphoid enhancer-binding factor 1 (LEF1), a crucial transcription factor of the Wnt/ß-catenin pathway and a member of the LEF/T-cell factor (TCF) family [34].